Haibo Shen (H B Shen)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Combination Therapy

Radical Prostatectomy

Editorial Comment

Long Non Coding Rna

Top Venues

International journal of general medicine

Pharmacogenomics and personalized medicine

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Huangqi Duan, Yu Shen, Chen Wang, Weimin Xia, Shun Zhang, Shenggen Yu, Ding Xu, Qifeng Cao, Hailong Liu, Haibo Shen
Cuproptosis-Related lncRNAs Modulate the Prognosis of MIBC by Regulating the Expression Pattern of Immunosuppressive Molecules Within the Tumor Microenvironment. International journal of general medicine 17 (2024)
Huangqi Duan, Yu Shen, Chen Wang, Weimin Xia, Shun Zhang, Shenggen Yu, Ding Xu, Qifeng Cao, Hailong Liu, Haibo Shen
Cuproptosis-Related lncRNAs Modulate the Prognosis of MIBC by Regulating the Expression Pattern of Immunosuppressive Molecules Within the Tumor Microenvironment. International journal of general medicine 17 (2024)
Chen Wang, Qifeng Cao, Shun Zhang, Hailong Liu, Huangqi Duan, Weimin Xia, Haibo Shen, Cheng Wang
Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line. Pharmacogenomics and personalized medicine 16 (2023)
Chen Wang, Qifeng Cao, Shun Zhang, Hailong Liu, Huangqi Duan, Weimin Xia, Haibo Shen, Cheng Wang
Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line. Pharmacogenomics and personalized medicine 16 (2023)
Weimin Xia, Shun Zhang, Huangqi Duan, Chen Wang, Su-Bo Qian, Haibo Shen
The combination therapy of Everolimus and anti-PD-1 improves the antitumor effect by regulating CD8 + T cells in bladder cancer. Medical oncology (Northwood, London, England) 39 (3) (2022)
Subo Qian, Shun Zhang, Weimin Xia, Ding Xu, Jun Qi, Haibo Shen, Yu Wu
Correlation of prostatic morphological parameters and clinical progression in aging Chinese men with benign prostatic hyperplasia: Results from a cross-sectional study. The Prostate 81 (8) (2021)
Shun Zhang, Cheng Wang, Weimin Xia, Huangqi Duan, Su-Bo Qian, Haibo Shen
Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer. International journal of general medicine 14 (2021)
Subo Qian, Weimin Xia, Yu Wu, Qifeng Cao, Yu Ding, Yunteng Huang, Haibo Shen
Urinary kidney injury molecule-1: a novel biomarker to monitor renal function in patients with unilateral ureteral obstruction. International urology and nephrology 52 (11) (2020)
Y Wu, Y Ding, Q F Cao, S B Qian, C Wang, H Q Duan, J Gu, Haibo Shen
The relationship between glucose homeostasis status and prostate size in aging Chinese males with benign prostatic hyperplasia. World journal of urology 38 (11) (2020)
Yu Ding, Qifeng Cao, Subo Qian, Xiaolong Chen, Yuhong Xu, Jian Chen, Haibo Shen
Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 39 (4) (2019)
Qifeng Cao, Chen Wang, Yu Ding, Ding Xu, Subo Qian, Haibo Shen, Jun Qi
ARID1A upregulation predicts better survival in patients with urothelial bladder carcinoma. The Journal of international medical research 48 (4) (2019)